These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1584596)

  • 21. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytoprotective effect of Amifostine in the combined chemotherapy of advanced ovarian carcinoma].
    Nagy P; Kádasi L
    Orv Hetil; 2000 Sep; 141(37):2027-30. PubMed ID: 11037611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.
    Erickson LD; Hartmann LC; Su JQ; Nielsen SN; Pfeifel DM; Goldberg RM; Levitt R; Stanhope CR
    Gynecol Oncol; 1994 Aug; 54(2):196-200. PubMed ID: 8063245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: Long-term prognosis after five years.
    Mizutani K; Takeuchi S; Ohashi Y; Yakushiji M; Nishimura H; Takahashi T; Maruhashi T; Ueda K; Noda K; Watanabe Y; Kawana T; Terashima Y; Ochiai K; Goto S; Takaku F; Motoyoshi K
    Oncol Rep; 2003; 10(1):127-31. PubMed ID: 12469157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
    Gadducci A; Carnino F; Chiara S; Brunetti I; Tanganelli L; Romanini A; Bruzzone M; Conte PF
    Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined therapy of ovarian cancer (author's transl].
    Vahrson H; Wolf A; Jankowski R
    Geburtshilfe Frauenheilkd; 1977 Feb; 37(2):131-8. PubMed ID: 838261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of gynecologic neoplasms in internal medicine].
    Mayr AC
    Schweiz Med Wochenschr; 1978 Sep; 108(35):1369-73. PubMed ID: 80032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Control of the response of ovarian cancers to cytostatic therapy and the value of the second-look operation].
    Teufel G; Meerpohl HG; Pfleiderer A
    Onkologie; 1985 Dec; 8(6):356-63. PubMed ID: 3912693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic Sertoli-Leydig cell tumor of the ovary during pregnancy treated by BV-CAP chemotherapy.
    Pride GL; Pollock WJ; Norgard MJ
    Am J Obstet Gynecol; 1982 May; 143(2):231-3. PubMed ID: 6177244
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study of results obtained by various methods of cyclophosphamide therapy in advanced cancer of the ovary].
    Krommer K; Csaba I; Keller G
    Orv Hetil; 1976; 117(20):1205-7. PubMed ID: 1272567
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results obtained with chemotherapy of ovarian cancer respecting its morphological structure (author's transl)].
    Skoda V; Cizková J; Hrádek D; Jandová A; Janousková M; Laurová L
    Cesk Gynekol; 1976 Dec; 41(10):716-17. PubMed ID: 1036972
    [No Abstract]   [Full Text] [Related]  

  • 36. [Correlation of histological findings and immediate therapeutical effect of cytostatic treatment in ovarian carcinoma].
    Popović ND; Nikolin L
    Med Pregl; 1976; 29(9-10):411-3. PubMed ID: 1004385
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chemotherapy as a part of a complex treatment of ovarian cancer (author's transl)].
    Kucera F; Ptácková B
    Cesk Gynekol; 1976 Dec; 41(10):721-2. PubMed ID: 1009602
    [No Abstract]   [Full Text] [Related]  

  • 38. Response of endometrioid ovarian carcinoma in nude mice to the combination of vincristine sulphate and cyclophosphamide.
    Bjondahl K; Grönroos M; Klemi P; Möttönen M
    Acta Obstet Gynecol Scand; 1980; 59(5):439-43. PubMed ID: 7446010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University].
    Krommer K
    Orv Hetil; 1992 May; 133(19):1151-8. PubMed ID: 1584596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of 28 years of treating advanced ovarian cancer.
    Krommer CF; Szalai JP
    Anticancer Res; 1993; 13(3):817-25. PubMed ID: 8317918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.